Loading…
Caribou Biosciences, Inc. is projected to rise to $2.64 by 2027, a +37% move from its current price of $1.93. CRBU is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $1.87 | $1.93 | $1.99 | +0.05% |
| Jul 14 | $1.84 | $1.93 | $2.01 | +0.10% |
| Jul 15 | $1.83 | $1.93 | $2.04 | +0.16% |
| Jul 16 | $1.81 | $1.93 | $2.05 | +0.21% |
| Jul 17 | $1.80 | $1.93 | $2.07 | +0.26% |
| Jul 18 | $1.79 | $1.93 | $2.08 | +0.31% |
| Jul 19 | $1.78 | $1.93 | $2.10 | +0.36% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.78 | $1.93 | $2.10 | +0.36% |
| Week 2 | $1.72 | $1.94 | $2.18 | +0.73% |
| Week 3 | $1.69 | $1.95 | $2.25 | +1.09% |
| Week 4 | $1.65 | $1.95 | $2.30 | +1.46% |
| Week 5 | $1.63 | $1.96 | $2.36 | +1.82% |
| Week 6 | $1.61 | $1.97 | $2.41 | +2.19% |
| Week 7 | $1.59 | $1.97 | $2.46 | +2.56% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company.
The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma.
Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
Caribou Biosciences, Inc. is trading at $1.82 per share. Its market capitalization is $180.51M and it holds a rank of 3789. The forecasted price path shows upside over the long term, with the average price rising across the years and high upside by 2050.
The 30-day price range spans from $1.45 to $2.29, reflecting a volatile near-term trading environment.
A major floor 42.1% below — a decisive break under it would weaken the trend.
The nearest floor, 18.4% below — buyers have tended to step in here.
The nearest ceiling, 26.2% above — a clean break opens room to run.
A major ceiling 47.3% above — clearing it would confirm fresh momentum.
Key CRBU support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CRBU market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.91 | Buy | $1.90 | Buy |
| MA 10 | $1.83 | Buy | $1.85 | Buy |
| MA 20 | $1.74 | Buy | $1.83 | Buy |
| MA 50 | $1.92 | Buy | $1.88 | Buy |
| MA 100 | $1.93 | Sell | $1.89 | Buy |
| MA 200 | $1.94 | Sell | $1.88 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.73 | Neutral |
| Stoch RSI (14) | 94.78 | Sell |
| CCI (20) | 121.86 | Buy |
| Williams %R (14) | -4.05 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | 15.96 | Buy |
| Bollinger %B (20,2) | 0.90 | Neutral |
| Stochastic %K (14) | 95.95 | Sell |
| TRIX (15) | -0.41 | Sell |
| Awesome (5,34) | 0.02 | Buy |
| Ultimate (7,14,28) | 80.25 | Sell |
| Momentum (10) | 0.35 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 1.98 | Sell |
| ADX (14) | 17.20 | Neutral |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is bullish. RSI14 is 50, sitting at the middle of the typical range. The 50-day SMA is $1.95 and the 200-day SMA is $1.93, indicating a mild positive crossover context. Support is listed at $1.57 and resistance at $2.43, creating a defined near-term trading band.
Over the last 30 days, the price has moved within a range of $1.45 to $2.29.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.39 | $1.93 | $2.85 | 0% | Neutral | |
| $2.07 | $2.64 | $3.57 | +37% | Bullish | |
| $2.29 | $3.01 | $4.24 | +56% | Bullish | |
| $2.28 | $3.08 | $4.49 | +60% | Bullish | |
| $2.22 | $3.07 | $4.59 | +59% | Bullish | |
| $2.73 | $3.86 | $5.92 | +100% | Bullish | |
| $3.17 | $4.57 | $7.16 | +138% | Bullish | |
| $3.42 | $5.04 | $8.04 | +162% | Bullish | |
| $3.85 | $5.78 | $9.39 | +200% | Bullish | |
| $3.68 | $5.62 | $9.28 | +192% | Bullish | |
| $5.66 | $9.37 | $16.56 | +387% | Bullish | |
| $10.07 | $19.19 | $37.41 | +897% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.39 | $1.93 | $2.40 | +0.00% |
| August 2026 | $1.72 | $2.04 | $2.48 | +5.77% |
| September 2026 | $1.69 | $2.02 | $2.49 | -0.89% |
| October 2026 | $1.75 | $2.11 | $2.63 | +4.35% |
| November 2026 | $1.84 | $2.22 | $2.80 | +5.54% |
| December 2026 | $1.85 | $2.25 | $2.85 | +1.03% |
Click any year to see its month-by-month CRBU forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The CRBU price prediction for 2026 points to an average of $1.93 (low $1.39, high $2.85) — a potential gain of 0% on today's $1.93. A consolidation phase looks the most probable path here.
In 2027, CRBU is projected to trade between $2.07 and $3.57, averaging $2.64 — a potential gain of +37% from today's $1.93. That is up +37% on the projected 2026 average. Momentum favours further upside here.
Caribou Biosciences, Inc.'s 2028 outlook centres on $3.01, within a $2.29 to $4.24 range. That is up +14% on the projected 2027 average. That marks a +56% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, CRBU could reach as high as $4.49, with a base case around $3.08 and support toward $2.28 — roughly +60% from $1.93. Momentum favours further upside here.
Expect CRBU to range from $2.22 to $4.59 through 2030. The $3.07 average target implies a +59% move from current prices. That is 0% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
The CRBU price prediction for 2031 points to an average of $3.86 (low $2.73, high $5.92) — a potential gain of +100% on today's $1.93. Momentum favours further upside here.
In 2032, CRBU is projected to trade between $3.17 and $7.16, averaging $4.57 — a potential gain of +138% from today's $1.93. That is up +18% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Caribou Biosciences, Inc.'s 2033 outlook centres on $5.04, within a $3.42 to $8.04 range. That is up +10% on the projected 2032 average. That marks a +162% change versus current levels. Momentum favours further upside here.
By 2034, CRBU could reach as high as $9.39, with a base case around $5.78 and support toward $3.85 — roughly +200% from $1.93. Buyers look set to stay in control over this stretch.
Expect CRBU to range from $3.68 to $9.28 through 2035. The $5.62 average target implies a +192% move from current prices. That is -3% versus the projected 2034 average. Momentum favours further upside here.
The CRBU price prediction for 2040 points to an average of $9.37 (low $5.66, high $16.56) — a potential gain of +387% on today's $1.93. Buyers look set to stay in control over this stretch.
In 2050, CRBU is projected to trade between $10.07 and $37.41, averaging $19.19 — a potential gain of +897% from today's $1.93. That is up +105% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in CRBU today (≈ 519.480519 CRBU) could be worth
$9,969.36
+$8,969.36 (+897%) by 2050 · US Dollar
Based on the average projected CRBU price of $19.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CRBUwould be worth at today's price.
$1,000 invested in CRBU on Jul 10, 2025 (≈ 574.712641 CRBU) would be worth
$1,106.32
+$106.32 (+10.6%) today · 1.11× · US Dollar
Based on a CRBU entry price of $1.74 vs. today's $1.93.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.82 | $1,057.69 | +5.8% |
| 1 month ago | $1.79 | $1,075.42 | +7.5% |
| 3 months ago | $1.93 | $997.41 | -0.3% |
| 6 months ago | $1.58 | $1,218.35 | +21.8% |
| 1 year ago | $1.74 | $1,106.32 | +10.6% |
| All time (5.0y) ago | $16.32 | $117.95 | -88.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CRBU forecast.
Our base-case forecast reaches $3.90 around 2032.
Implied market cap at $3.90: $386.8M
The multi-year forecast shows a neutral start in 2026, with an average price of $1.82. From 2027 onward the outlook turns bullish, with 2027 average $2.52 and 2028 average $2.78; 2029 average $2.77 and 2030 average $2.74.
By 2031 the average rises to $3.37, then to $3.93 (2032) and $4.39 (2033), $5.01 (2034), and $4.73 (2035). The 2040 forecast envisions an average of $7.76 and a max of $14.26, with a min of $4.45. By 2050 the average price is projected at $15.32 and the max at $31.25, with a min of $7.42.
Overall, the range of outcomes includes a max ROI of 741.5% in 2050 and a sequence of bullish sentiment for most years, noting these are estimates rather than guarantees.
Tap a question to reveal the answer.
In 2030 the forecast shows min $1.93, avg $2.74, max $4.21 and ROI 50.4%; sentiment BULLISH.
The forecast shows neutral near-term in 2026 and bullish momentum from 2027 onward, with a high-end 2050 estimate of avg $15.32, max $31.25 and ROI up to 741.5%; these are estimates, not guarantees.
2035 forecast shows min $2.98, avg $4.73, max $8.08 and ROI 159.9%; sentiment BULLISH.
Current price $1.82; market cap $180.51M; rank 3789.
By 2050 the average price is forecast at $15.32 with a max of $31.25 and min $7.42; ROI 741.5%; 2040 average $7.76, max $14.26; 2040 min $4.45; sentiment BULLISH.
Caribou Biosciences, Inc. Community Discussion
0Share your Caribou Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.